Roche on EU carpet over unreported US AEs
This article was originally published in Scrip
Executive Summary
The European Medicines Agency has ordered Roche to rapidly put its house in order as it assesses the impact of the Swiss company's failure to pass on up to 80,000 adverse event reports for its medicines from the US to the EU.